Therapy Areas
15 February 2019 - - German pharmaceutical company Boehringer Ingelheim and US-based Eli Lilly and Company's (NYSE: LLY) CAROLINA (CARdiovascular Outcome study of LINAgliptin versus glimepiride in patients with type 2 diabetes) met its prim...
15 February 2019 - - The first subject has been dosed with ASP3772, US-based Affinivax, Inc.'s novel MAPS vaccine targeting Streptococcus pneumoniae (pneumococcus), the company said.

The clinical study protocol "A Pha...
15 February 2019 - - US-based biopharmaceutical company Merck (NYSE: MRK) has presented interim data from the Phase 1b/2 KEYNOTE-365 umbrella trial investigating Keytruda, Merck's anti-PD-1 therapy, in combination with various agents for the tre...
15 February 2019 - Public health agency The U.S. Food and Drug Administration Thursday granted approval of the marketing of the Tandem Diabetes Care t:Slim X2 insulin pump with interoperable technology (interoperable t:Slim X2) for delivering insulin...
14 February 2019 - - US-based biotechnology company Moderna, Inc., (NASDAQ: MRNA) has received topline data from the first planned interim analysis of safety and immunogenicity from its Phase 1 study of mRNA-1653 in healthy adults, the company said.<...
14 February 2019 - - US-based biotechnology company Exelixis, Inc. (NASDAQ: EXEL) is initiating phase 1 clinical development for XL092, the first internally-discovered Exelixis compound to enter the clinic following the company's reinitiation of...
14 February 2019 - BioArctic AB (STO:BIOAB), a Swedish research-based biopharmaceutical company, announced on Wednesday that the first patient in the second panel of the phase 1/2 study has now been treated with SC0806.Reportedly, this implies that t...